Renaissance Technologies LLC Lowers Stock Holdings in Privia Health Group, Inc. (NASDAQ:PRVA)

Renaissance Technologies LLC lessened its stake in Privia Health Group, Inc. (NASDAQ:PRVA - Free Report) by 18.1% in the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 218,100 shares of the company's stock after selling 48,200 shares during the quarter. Renaissance Technologies LLC owned about 0.18% of Privia Health Group worth $4,264,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also bought and sold shares of PRVA. Riverbridge Partners LLC raised its position in Privia Health Group by 19.7% in the fourth quarter. Riverbridge Partners LLC now owns 5,824,458 shares of the company's stock valued at $113,868,000 after purchasing an additional 958,418 shares during the last quarter. Geode Capital Management LLC increased its stake in shares of Privia Health Group by 1.0% in the third quarter. Geode Capital Management LLC now owns 2,415,022 shares of the company's stock valued at $43,986,000 after buying an additional 23,178 shares during the period. Loomis Sayles & Co. L P raised its position in shares of Privia Health Group by 55.0% during the fourth quarter. Loomis Sayles & Co. L P now owns 1,418,234 shares of the company's stock worth $27,727,000 after acquiring an additional 503,002 shares during the last quarter. Franklin Resources Inc. boosted its holdings in Privia Health Group by 0.8% in the fourth quarter. Franklin Resources Inc. now owns 1,311,166 shares of the company's stock valued at $25,633,000 after acquiring an additional 10,926 shares during the last quarter. Finally, Charles Schwab Investment Management Inc. increased its position in Privia Health Group by 6.5% during the 4th quarter. Charles Schwab Investment Management Inc. now owns 1,133,873 shares of the company's stock valued at $22,167,000 after purchasing an additional 69,649 shares during the period. Institutional investors own 94.48% of the company's stock.

Insider Buying and Selling

In other Privia Health Group news, CFO David Mountcastle sold 5,630 shares of the business's stock in a transaction dated Wednesday, April 2nd. The stock was sold at an average price of $22.38, for a total transaction of $125,999.40. Following the sale, the chief financial officer now owns 179,676 shares in the company, valued at approximately $4,021,148.88. The trade was a 3.04 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. 10.70% of the stock is owned by corporate insiders.

Privia Health Group Stock Up 0.3 %

PRVA stock traded up $0.07 during midday trading on Thursday, hitting $23.46. The company's stock had a trading volume of 466,153 shares, compared to its average volume of 777,860. The firm has a market capitalization of $2.85 billion, a price-to-earnings ratio of 234.62, a price-to-earnings-growth ratio of 3.47 and a beta of 0.88. Privia Health Group, Inc. has a 12 month low of $15.92 and a 12 month high of $26.04. The company has a 50 day moving average of $23.72 and a two-hundred day moving average of $21.78.

Analysts Set New Price Targets

Several equities research analysts have recently weighed in on PRVA shares. Needham & Company LLC reiterated a "buy" rating and set a $30.00 price objective on shares of Privia Health Group in a research report on Thursday, April 10th. Barclays increased their price target on Privia Health Group from $21.00 to $23.00 and gave the stock an "equal weight" rating in a report on Thursday, April 10th. Truist Financial boosted their target price on shares of Privia Health Group from $27.00 to $28.00 and gave the company a "buy" rating in a research report on Thursday, April 10th. Piper Sandler raised their price target on shares of Privia Health Group from $25.00 to $40.00 and gave the stock an "overweight" rating in a report on Friday, February 28th. Finally, JMP Securities set a $29.00 price objective on shares of Privia Health Group in a report on Friday, February 28th. One research analyst has rated the stock with a hold rating, twelve have given a buy rating and two have issued a strong buy rating to the company. According to data from MarketBeat.com, Privia Health Group currently has an average rating of "Buy" and an average price target of $27.14.

About Privia Health Group

Privia Health Group, Inc operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings.